已收盘 03-27 16:00:00 美东时间
-0.690
-3.95%
今日重点评级关注:HC Wainwright & Co.:维持NovoCure"买入"评级,目标价从47美元升至49美元;Citizens:维持Ironwood医药"跑赢大市"评级,目标价从8美元升至10美元
02-27 11:07
今日重点评级关注:巴克莱:维持Vir Biotechnology"超配"评级,目标价从26美元升至30美元;巴克莱:维持Iovance Biotherapeutics"超配"评级,目标价从10美元升至11美元
02-26 09:30
Wells Fargo analyst Brandon Couillard maintains CareDx (NASDAQ:CDNA) with a Equal-Weight and raises the price target from $18 to $21.
02-25 22:49
<span style="color:#999999;">编者按:聚焦公司高管观点与展望,深挖业绩背后的信息,助力投资者把握先机。</span><blockquote><p><span style="color:#fa1432;"><strong>业绩回顾</strong></span></p></blockquote><p>• 根据CareDx业绩会实录,以下是财务业绩回顾摘要: ## 1. 财务业绩 **2025年第四季度业绩:** - 总营收:1.084亿美元,同比增长25% - 检测服务营收:7,840万美元,同比增长23% - 患者和数字解决方案营收:1,680万美元,同比增长47% - 实验室产品营收:1,330万美元,同比增长17% - 检测量:约53,000次,同比增长17% - Non-GAAP毛利润:7,430万美元,毛利率68.5% - 调整后EBITDA:650万美元,同比下降34% - 现金收款:1.158亿美元,同比增长37% **2025年全年业
02-25 12:13
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. The Board of Directors of the Company has appointed Keith Kennedy as
02-25 05:54
The Q4 earnings report for CareDx (NASDAQ:CDNA) was released on Tuesday, Februa...
02-25 05:02
Companies Reporting Before The Bell • China Yuchai Intl (NYSE:CYD) is expected ...
02-24 19:11
CareDx (NASDAQ:CDNA) will release its quarterly earnings report on Tuesday, 202...
02-24 05:02
CareDx (NASDAQ:CDNA) raises FY2025 sales outlook from $372.000 million-$376.000 million to $380.000 million vs $373.999 million estimate.
01-12 20:07
CareDx (NASDAQ:CDNA) sees Q4 sales of $108.000 million vs $102.584 million analyst estimate.
01-12 20:06